Abstract：Parenteral nutrition (PN) serves as an important therapeutic modality in all clinical departments, which can improve
the nutritional intake and nutritional status of patients, and improve the clinical outcome of patients. PN is one of the most risky
forms of medication. That is used for a variety of indications, has diverse prescription components and infusion approaches. There
are many differences between doctors of different specialties in the grasp of indications, prescription components, infusion route
selection and other aspects, which may lead to safety PN problems, even to death. To improve the safety of parenteral nutrition
for Chinese clinicians and maximize the clinical benefits of parenteral nutrition. Chinese Society of Nutritional Oncology, Chinese
Society of Parenteral and Enteral Nutrition organized experts to formulate this consensus. This consensus according to Chinese
nutrition diagnosis and treatment status, published evidence, combined with clinical, pharmaceutical, nutrition, nursing and other
fields of expertise. These consensus recommendations are based on practices and Oxford Center for Evidence⁃based Medicine
(OCEBM) grading standards that are generally accepted to minimize errors with PN therapy, categorized in the areas of PN
prescribing, compounding, infusion route selection, and complications administration.
中国抗癌协会肿瘤营养专业委员会，中华医学会肠外肠内营养学分会. 肠外营养安全性管理中国专家共识[J]. 肿瘤代谢与营养电子杂志, 2021, 8(5): 495-502.
Chinese Society of Nutritional Oncology, Chinese Society for Parenteral and Enteral Nutrition. Chinese expert consensus on the safety of parenteral nutrition. Electron J Metab Nutr Cancer, 2021, 8(5): 495-502.
